CRISPR

CRISPR1-mgat1a

ID
ZDB-CRISPR-251210-11
Name
CRISPR1-mgat1a
Previous Names
None
Target
Sequence
5' - TGTCTTTGCGCTGATCAGGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ecu301 mgat1a
Expression
Gene expression in Wild Types + CRISPR1-mgat1a
No data available
Phenotype
Phenotype resulting from CRISPR1-mgat1a
No data available
Phenotype of all Fish created by or utilizing CRISPR1-mgat1a
Phenotype Fish Conditions Figures
heart protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 3. with image from Hall et al., 2025
swimming behavior decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 6. with image from Hall et al., 2025
brain protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 3. with image from Hall et al., 2025
integument protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 2. with image from Hall et al., 2025
brain protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 2. with image from Hall et al., 2025
swim bladder protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 3. with image from Hall et al., 2025
swim bladder protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 2. with image from Hall et al., 2025
heart protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 2. with image from Hall et al., 2025
spinal cord protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 2. with image from Hall et al., 2025
whole organism protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 3. with image from Hall et al., 2025
locomotory exploration behavior process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 7. with image from Hall et al., 2025
thigmotaxis decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 5. with image from Hall et al., 2025
skeletal muscle protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 3. with image from Hall et al., 2025
skeletal muscle protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 2. with image from Hall et al., 2025
spinal cord protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 3. with image from Hall et al., 2025
integument protein N-acetylglucosaminyltransferase activity decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 3. with image from Hall et al., 2025
locomotory behavior decreased process quality, abnormal mgat1aecu301/ecu301 (AB) standard conditions Figure 4. with image from Hall et al., 2025
Citations